450 filings
Page 19 of 23
UPLOAD
sal1e
27 Aug 15
Letter from SEC
12:00am
S-3
kk44aul2
20 Aug 15
Shelf registration
12:00am
8-K
rvb 6q38cp13vzlpg7
14 Aug 15
Recro Pharma Reports Second Quarter 2015 Financial Results
12:00am
424B3
utwfgqgz20cs
14 Aug 15
Prospectus supplement
12:00am
S-8
jvoy42jw0 ewyc37i0
12 Aug 15
Registration of securities for employees
12:00am
424B3
dunvj6ajv5c31eoqn
24 Jul 15
Prospectus supplement
12:00am
8-K
t3xm lj1z
24 Jul 15
Recro Pharma Announces Additional Information for Phase II Clinical Trial of Dex-IN
12:00am
8-K/A
850aef74hsyndgwwouq
21 Jul 15
Condensed Combined Financial Statements
12:00am
424B3
oub ci37x
21 Jul 15
Prospectus supplement
12:00am
8-K
t1poku8p
17 Jul 15
Recro Pharma Announces Positive Top-Line Results for Phase II Clinical Trial of Dex-IN
12:00am
424B3
0v5zr
17 Jul 15
Prospectus supplement
12:00am
424B3
ttmyn29brmsfdmd
17 Jul 15
Prospectus supplement
12:00am
8-K
rf0n4 e60phw8
16 Jul 15
Entry into a Material Definitive Agreement
12:00am
D
33pear5n06mxd4hx 6hu
13 Jul 15
$16M in equity, sold $16M, 3 investors
12:00am
8-K
31qzsn
8 Jul 15
Recro Pharma Announces $16 Million Financing
12:00am
424B3
sqnhp5eumqhhz8 lc9y
8 Jul 15
Prospectus supplement
12:00am
424B3
amtuhi94o2nuw6
30 Jun 15
Prospectus supplement
12:00am
8-K/A
j26vnawww glp
26 Jun 15
Financial Statements and Exhibits
12:00am
8-K
4gkthllgop
26 Jun 15
Departure of Directors or Certain Officers
12:00am